Arsenic	JJ
trioxide	NN
inhibits	VBZ
transforming-growth-factor-b1-induced	JJ
fibroblast	NN
to	TO
myofibroblast	NN
differentiation	NN
in	FW
vitro	FW
and	CC
bleomycin	NN
induced	VBD
lung	NN
fibrosis	NN
in	FW
vivo	FW
.	.

BACKGROUND	NN
:	:
Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
progressive	JJ
disease	NN
of	IN
insidious	JJ
onset	NN
,	,
and	CC
is	VBZ
responsible	JJ
for	IN
up	RB
to	TO
30,000	CD
deaths	NNS
per	IN
year	NN
in	IN
the	DT
U.S.	NNP
Excessive	JJ
production	NN
of	IN
extracellular	JJ
matrix	NN
by	IN
myofibroblasts	NNS
has	VBZ
been	VBN
shown	VBN
to	TO
be	VB
an	DT
important	JJ
pathological	JJ
feature	NN
in	IN
IPF	NN
.	.

TGF-b1	NN
is	VBZ
expressed	VBN
in	IN
fibrotic	JJ
lung	NN
and	CC
promotes	VBZ
fibroblast	NN
to	TO
myofibroblast	NN
differentiation	NN
(	(
FMD	NN
)	)
as	RB
well	RB
as	IN
matrix	NN
deposition	NN
.	.

METHODS	NNS
:	:
To	TO
identify	VB
the	DT
mechanism	NN
of	IN
Arsenic	JJ
trioxide	NN
's	POS
(	(
ATO	NN
)	)
's	POS
anti-fibrotic	JJ
effect	NN
in	FW
vitro	FW
,	,
normal	JJ
human	JJ
lung	NN
fibroblasts	NNS
(	(
NHLFs	NNS
)	)
were	VBD
treated	VBN
with	IN
ATO	NN
for	IN
24	CD
hours	NNS
and	CC
were	VBD
then	RB
exposed	VBN
to	TO
TGF-b1	NN
(	(
1	CD
ng/ml	NN
)	)
before	IN
harvesting	VBG
at	IN
multiple	JJ
time	NN
points	NNS
.	.

To	TO
investigate	VB
whether	IN
ATO	NNP
is	VBZ
able	JJ
to	TO
alleviate	VB
lung	NN
fibrosis	NN
in	FW
vivo	FW
,	,
C57BL/6	NN
mice	NNS
were	VBD
administered	VBN
bleomycin	NN
by	IN
oropharyngeal	NN
aspiration	NN
and	CC
ATO	NN
was	VBD
injected	VBN
intraperitoneally	RB
daily	RB
for	IN
14	CD
days	NNS
.	.

Quantitative	JJ
real-time	JJ
PCR	NN
,	,
western	NN
blotting	NN
,	,
and	CC
immunofluorescent	JJ
staining	NN
were	VBD
used	VBN
to	TO
assess	VB
the	DT
expression	NN
of	IN
fibrotic	JJ
markers	NNS
such	JJ
as	IN
a-smooth-muscle-actin	NN
(	(
a-SMA	NN
)	)
and	CC
a-1	NN
type	NN
I	CD
collagen	NN
.	.

RESULTS	NNS
:	:
Treatment	NN
of	IN
NHLFs	NNS
with	IN
ATO	NN
at	IN
very	RB
low	JJ
concentrations	NNS
(	(
10-20nM	NN
)	)
inhibits	VBZ
TGF-b1-induced	JJ
a-smooth-muscle-actin	NN
(	(
a-SMA	NN
)	)
and	CC
a-1	NN
type	NN
I	CD
collagen	NN
mRNA	NN
and	CC
protein	NN
expression	NN
.	.

ATO	NNP
also	RB
diminishes	VBZ
the	DT
TGF-b1-mediated	JJ
contractile	NN
response	NN
in	IN
NHLFs	NNS
.	.

ATO	NNP
's	POS
down-regulation	NN
of	IN
profibrotic	JJ
molecules	NNS
is	VBZ
associated	VBN
with	IN
inhibition	NN
of	IN
Akt	NN
,	,
as	RB
well	RB
as	IN
Smad2/Smad3	NN
phosphorylation	NN
.	.

TGF-b1-induced	JJ
H2O2	NN
and	CC
NOX-4	NN
mRNA	NN
expression	NN
are	VBP
also	RB
blocked	VBN
by	IN
ATO	NNP
.	.

ATO-mediated	JJ
reduction	NN
in	IN
Smad3	NN
phosphorylation	NN
correlated	VBD
with	IN
a	DT
reduction	NN
of	IN
promyelocytic	JJ
leukemia	NN
(	(
PML	NN
)	)
nuclear	JJ
bodies	NNS
and	CC
PML	NN
protein	NN
expression	NN
.	.

PML	NN
-	:
/	:
-	:
mouse	NN
embryonic	JJ
fibroblasts	NNS
(	(
MEFs	NNS
)	)
showed	VBD
decreased	VBN
fibronectin	NN
and	CC
PAI-1	NN
expression	NN
in	IN
response	NN
to	TO
TGF-b1	NN
.	.

Daily	NNP
intraperitoneal	JJ
injection	NN
of	IN
ATO	NNP
(	(
1	CD
mg/kg	NN
)	)
in	IN
C57BL/6	NN
mice	NNS
inhibits	VBZ
bleomycin	NN
induced	VBD
lung	NN
a-1	NN
type	NN
I	CD
collagen	NN
mRNA	NN
and	CC
protein	NN
expression	NN
.	.

CONCLUSIONS	NNS
:	:
In	IN
summary	NN
,	,
these	DT
data	NNS
indicate	VBP
that	IN
low	JJ
concentrations	NNS
of	IN
ATO	NNP
inhibit	VBP
TGF-b1-induced	JJ
fibroblast	NN
to	TO
myofibroblast	NN
differentiation	NN
and	CC
decreases	VBZ
bleomycin	NN
induced	VBD
pulmonary	JJ
fibrosis	NN
.	.

